- Millennium enters five-year oncology test deal with Becton
- TriPath to develop cancer tests for BD and Millennium
- Bayer AG acquires Chiron Diagnostics for $1.1bn in cash
- AutoCyte, NeoPath merge in $101mm stock swap
- TriPath buys bankrupt Neuromedical's assets
- AutoCyte licenses to NeoPath newly acquired patents
- TriPath buys CAS from Becton
- Applied Imaging and Dako combine diagnostic technologies
- Dako to distribute ImmunoCyt in US for DiagnoCure
- ChromaVision and Dako work together on breast cancer test
Ask The Analyst
Ask the Analyst is free for subscribers. Submit your question and one of our analysts will be in touch.
Your question has been successfully sent to the email address below and we will get back as soon as possible. email@example.com.
All fields are required.
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.